CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Open-market buy President & COO bought 3,000 shares at $2.52 ($7,560)
- 10-Q Report Quarterly Report
- 4 Open-market buy CFO bought 10,000 shares at $2.86 ($28,600)
- 4 Open-market buy Director bought 20,000 shares at $2.95 ($59,000)
- 4 Open-market buy Director bought 10,000 shares at $4.37 ($43,691)
- 8-K Event Results of operations · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 50,000 shares at $4.00 ($200,000)
- 8-K Event Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- 4 Gift CFO gave 6,000 shares (gift)
- 10-Q Report Quarterly Report
Page 30 of 61 · 1,213 filings